Design-based stereological analysis of the lung parenchymal architecture and alveolar type II cells in surfactant protein A and D double deficient mice

Anatomical Record - Part A Discoveries in Molecular, Cellular, and Evolutionary Biology

Volumn 286, Issue 2, 2005, Pages 885-890

  Jung, Anja ^a   Allen, Lennell ^b   Nyengaard, Jens R ^c   Gundersen, Hans Jørgen G ^c   Richter, Joachim ^a   Hawgood, Samuel ^b   Ochs, Matthias ^a,b,d  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Alveoli; Collecting; Lamellar bodies; SP A; SP D; Stereology; Surfactant; Type II cells

Indexed keywords

COLLECTIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CELL METABOLISM; CELL SIZE; CELL TYPE; CONTROLLED STUDY; GENETIC MANIPULATION; IMMUNE RESPONSE; INFLAMMATION; KNOCKOUT MOUSE; LAMELLAR BODY; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG PARENCHYMA; LUNG STRUCTURE; LUNG VOLUME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN SECRETION; PROTEIN SYNTHESIS; STEREOLOGY;

ANIMALS; EPITHELIAL CELLS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D;

EID: 26444548121     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ar.a.20225     Document Type: Article

References (35)

1. Botas C, Poulain F, Akiyama J, Brown C, Allen L, Goerke J, Clements J, Carlson E, Gillespie AM, Epstein C, Hawgood S. 1998. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci USA 95:11869-11874.
2. Bryson DG, McConnell S, McAliskey M, McNulty MS. 1991. Ultrastructural features of alveolar lesions in induced respiratory syncytial virus pneumonia of calves. Vet Pathol 28:286-291.
3. Chabot S, Salez L, McCormack FX, Touqui L, Chignard M. 2003. Surfactant protein A inhibits lipopolysaccharide-induced in vivo production of interleukin-10 by mononuclear phagocytes during lung inflammation. Am J Respir Cell Mol Biol 28:347-353.
4. Crouch E, Wright JR. 2001. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 63:521-554.
5. Cruz-Orive LM, Weibel ER. 1990. Recent stereological methods for cell biology: a brief survey. Am J Physiol Lung Cell Mol Physiol 258:L148-L156.
6. Fehrenbach H, Ochs M. 1998. Studying lung ultrastructure. In: Uhlig S, Taylor AE, editors. Methods in pulmonary research. Basel: Birkhäuser. p 429-454.
7. Fehrenbach H, Brasch F, Uhlig S, Weisser M, Stamme C, Wendel A, Richter J. 1998. Early alterations in intracellular and alveolar surfactant of the rat lung in response to endotoxin. Am J Respir Crit Care Med 157:1630-1639.
8. Fehrenbach H. 2001. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2:33-46.
9. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, Henson PM. 2003. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115:13-23.
10. Gundersen HJG, Jensen EB. 1985. Stereological estimation of the volume-weighted mean volume of arbitrary particles observed on random sections. J Microsc 138:127-142.
11. Hawgood S, Poulain FR. 2001. The pulmonary collectins and surfactant metabolism. Annu Rev Physiol 63:495-519.
12. Hawgood S, Ochs M, Jung A, Akiyama J, Allen L, Brown C, Edmondson J, Levitt S, Carlson E, Gillespie AM, Villar A, Epstein CJ, Poulain FR. 2002. Sequential targeted deficiency of SP-A and -D leads to progressive alveolar lipoproteinosis and emphysema. Am J Physiol Lung Cell Mol Physiol 283:L1002-L1010.
13. Homer RJ, Zheng T, Chupp G, He S, Zhu Z, Chen Q, Ma B, Hite RD, Gobran LI, Rooney SA, Elias JA. 2002. Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure. Am J Physiol Lung Cell Mol Physiol 283:L52-L59.
14. Hyde DM, Tyler NK, Putney LF, Singh P, Gundersen HJG. 2004. Total number and mean size of alveoli in mammalian lung estimated using fractionator sampling and unbiased estimates of the Euler characteristic of alveolar openings. Anat Rec 277:216-226.
15. Ikegami M, Korfhagen TR, Bruno MD, Whitsett JA, Jobe AH. 1997. Surfactant metabolism in surfactant protein A-deficient mice. Am J Physiol Lung Cell Mol Physiol 272:L479-L485.
16. Ikegami M, Whitsett JA, Jobe A, Ross G, Fisher J, Korfhagen T. 2000a. Surfactant metabolism in SP-D gene-targeted mice. Am J Physiol Lung Cell Mol Physiol 279:L468-L476.
17. Ikegami M, Whitsett JA, Chroneos ZC, Ross GF, Reed JA, Bachurski CJ, Jobe AH. 2000b. IL-4 increases surfactant and regulates metabolism in vivo. Am J Physiol Lung Cell Mol Physiol 278:L75-L80.
18. Jain D, Dodia C, Bates SR, Hawgood S, Poulain FR, Fisher AB. 2003. SP-A is necessary for increased clearance of alveolar DPPC with hyperventilation or secretagogues. Am J Physiol Lung Cell Mol Physiol 284:L759-L765.
19. Kasper M, Haroske G. 1996. Alterations in alveolar epithelium after injury leading to pulmonary fibrosis. Histol Histopathol 11:463-483.
20. Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH, Wert SE, Stripp BR, Morris RE, Glasser SW, Bachurski CJ, Iwamoto HS, Whitsett JA. 1996. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 93:9594-9599.
21. Lesur O, Bouhadiba T, Melloni B, Cantin A, Whitsett JA, Begin R. 1995. Alterations of surfactant lipid turnover in silicosis: evidence of a role for surfactant-associated protein A (SP-A). Int J Exp Pathol 76:287-298.
22. McCormack FX, Whitsett JA. 2002. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 109:707-712.
23. Miller BE, Hook GE. 1990. Hypertrophy and hyperplasia of alveolar type II cells in response to silica and other pulmonary toxicants. Environ Health Perspect 85:15-23.
24. Ochs M, Nyengaard JR, Jung A, Knudsen L, Voigt M, Wahlers T, Richter J, Gundersen HJG. 2004a. The number of alveoli in the human lung. Am J Respir Crit Care Med 169:120-124.
25. Ochs M, Knudsen L, Allen L, Stumbaugh A, Levitt S, Nyengaard JR, Hawgood S. 2004b. GM-CSF mediates alveolar epithelial type II cell changes but not emphysema-like pathology in SP-D deficient mice. Am J Physiol Lung Cell Mol Physiol 287:L1333-L1341.
26. Scherle W. 1970. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26:57-60.
27. Sterio DC. 1984. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134:127-136.
28. Vedel Jensen EB, Gundersen HJG. 1993. The rotator. J Microsc 170:35-44.
29. Viviano CJ, Bakewell WE, Dixon D, Dethloff LA, Hook GE. 1995. Altered regulation of surfactant phospholipid and protein A during acute pulmonary inflammation. Biochim Biophys Acta 1259:235-244.
30. Weibel ER. 1979. Stereological methods: practical methods for biological morphometry. New York: Academic Press.
31. Wert SE, Yoshida M, LeVine AM, Ikegami M, Jones T, Ross GF, Fisher JH, Korfhagen TR, Whitsett JA. 2000. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci USA 97:5972-5977.
32. Wright JR. 1997. Immunomodulatory functions of surfactant. Physiol Rev 77:931-962.
33. Wright JR. 2004. Host defense functions of pulmonary surfactant. Biol Neonate 85:326-332.
34. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, Kim KS, McCormack FX. 2003. Surfactant proteins A and D inhibit the growth of gram-negative bacteria by increasing membrane permeability. J Clin Invest 111:1589-1602.
35. Yokohori N, Aoshiba K, Nagai A. 2004. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 125:626-632.